valsartan has been researched along with Alveolitis, Fibrosing in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hemmati, AA; Khodadadi, A; Mojiri-Forushani, H; Rashno, M | 1 |
| Liu, F; Xu, QY; Ye, YQ | 1 |
| Cai, Y; Chen, FP; Gong, LK; Li, XH; Liu, LL; Qi, XM; Ren, J; Wang, H; Wu, XF; Xiao, Y; Zhang, L | 1 |
| Millar, AB; Thickett, DR | 1 |
4 other study(ies) available for valsartan and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Valsartan attenuates bleomycin-induced pulmonary fibrosis by inhibition of NF-κB expression and regulation of Th1/Th2 cytokines.
Topics: Animals; Bleomycin; Gene Expression Regulation; Interferon-gamma; Interleukin-4; Male; NF-kappa B; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Th1 Cells; Th2 Cells; Valsartan | 2018 |
[Effects of valsartan on bleomycin-induced pulmonary fibrosis in rats and the expression of hepatocyte growth factor in lung tissue].
Topics: Animals; Hepatocyte Growth Factor; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan | 2005 |
Early lung injury contributes to lung fibrosis via AT1 receptor in rats.
Topics: Angiotensin II; Animals; Apoptosis; Collagen; Lipid Peroxidation; Male; Peptidyl-Dipeptidase A; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2007 |
Drug-induced antisynthetase syndrome.
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Anti-Inflammatory Agents; Arthritis; Autoantibodies; Autoimmune Diseases; Cytoskeleton; Humans; Male; Prednisolone; Pulmonary Fibrosis; Raynaud Disease; Skin Diseases; Syndrome; Tetrazoles; Valine; Valsartan | 1997 |